North America - December 17, 2020 - Health Canada, a government agency responsible for Canada's federal health policies, issued an "Important Safety Information" letter (RA-74549) warning healthcare providers about Elmiron (Pentosan Polysulfate Sodium) Pigmentary Maculopathy Risks. Health Canada announced two new updates concerning … [Read more...] about Health Canada Issues Important Safety Info to Healthcare Professionals Advising of Elmiron Pigmentary Maculopathy Risks